Status:
COMPLETED
Evaluation of New Feedback Canceller for Carina™ Implant
Lead Sponsor:
Cochlear
Conditions:
Hearing Loss
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to evaluate audio quality benefit for the patient implanted with a Cochlear or Otologics Carina implant with the new firmware (feedback canceller algorithm) whatever the p...
Eligibility Criteria
Inclusion
- successfully implanted with a commercial available CE-labelled implant device, resulting in measurable open set speech understanding
- native speaker in the language used to assess their clinical performance, i.e. French
Exclusion
- unwillingness or inability to comply with all of the investigational requirements
- additional handicaps that would prevent or restrict participation in the audiological evaluations
Key Trial Info
Start Date :
February 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT02309541
Start Date
February 1 2015
End Date
September 1 2017
Last Update
October 9 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Nord
Marseille, Bouches-du-Rhône, France, 13915
2
Hôpital Edouard Herriot
Lyon, Rhône, France, 69003
3
CHU Lyon Sud
Pierre-Bénite, Rhône, France, 69495